WORK Medical files six-month March 31, 2025 results

WORK Medical Technology Group LTD, a Cayman Islands company and foreign private issuer, filed a Form 6-K to furnish its unaudited consolidated financial statements and notes for the six months ended March 31, 2025.

Accepted by SEC EDGAR 08/25/2025 - 04:11 PM EDT Learn about SEC filing dates

Rhea-AI Filing Summary

WORK Medical Technology Group LTD, a Cayman Islands company and foreign private issuer, filed a Form 6-K to furnish its unaudited consolidated financial statements and notes for the six months ended March 31, 2025. These financial statements are provided as Exhibit 99.1.

The company also furnished Management’s Discussion and Analysis of Financial Condition and Results of Operations for the same six-month period as Exhibit 99.2. Additional Inline XBRL data files and the cover page interactive data file are included among the technical exhibits.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What does WORK Medical Technology Group LTD (WOK) report in this Form 6-K?

WORK Medical Technology Group LTD furnishes unaudited consolidated financial statements and notes for the six months ended March 31, 2025. It also provides Management’s Discussion and Analysis of Financial Condition and Results of Operations for the same period as a separate exhibit.

Which financial period is covered by WORK Medical Technology Group LTD’s unaudited statements?

The unaudited consolidated financial statements of WORK Medical Technology Group LTD cover the six months ended March 31, 2025. These statements, together with accompanying notes, are included as Exhibit 99.1 and form the core financial disclosure in this Form 6-K filing.

What is included in Exhibit 99.2 of WORK Medical Technology Group LTD’s 6-K?

Exhibit 99.2 contains Management’s Discussion and Analysis of Financial Condition and Results of Operations for the six months ended March 31, 2025. This narrative section discusses the company’s financial condition and operating performance for that six-month period in more detail.

What Inline XBRL materials accompany WORK Medical Technology Group LTD’s 6-K filing?

The filing includes an Inline XBRL instance document, taxonomy extension schema, calculation, definition, label, and presentation linkbase documents. A cover page interactive data file is also provided, helping present the Form 6-K cover information in machine-readable format for regulatory and analytical use.

Where is WORK Medical Technology Group LTD’s principal executive office located?

WORK Medical Technology Group LTD lists its principal executive office at Floor 23, No. 2 Tonghuinan Road, Xiaoshan District, Hangzhou City, Zhejiang Province, People’s Republic of China. This address identifies the main location of the company’s executive operations for corporate and regulatory purposes.

What type of annual report framework does WORK Medical Technology Group LTD use?

WORK Medical Technology Group LTD indicates it files annual reports under cover of Form 20-F, the standard for foreign private issuers. This framework aligns its ongoing annual disclosure, including audited financial statements, with U.S. securities regulations applicable to non-U.S. companies listed in the United States.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 6-K: How Foreign Companies Report to the SEC →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 6-K

REPORT OF FOREIGN PRIVATE ISSUER

PURSUANT TO RULE 13a-16 OR 15d-16

UNDER THE SECURITIES EXCHANGE ACT OF 1934

For the month of August 2025

Commission File Number: 001-42256

WORK Medical Technology Group LTD

Floor 23, No. 2 Tonghuinan Road

Xiaoshan District, Hangzhou City, Zhejiang Province, The People’s Republic of China

(Address of principal executive office)

Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F:

Form 20-F ☒        Form 40-F ☐

Explanatory Note

WORK Medical Technology Group LTD, a Cayman Islands company (the “Company”), is furnishing its unaudited financial statements and notes for the six months ended March 31, 2025. The financial statements and notes are attached as Exhibit 99.1 to this report. Management’s Discussion and Analysis of Financial Condition and Results of Operations for the six months ended March 31, 2025 is attached as Exhibit 99.2 to this report.

1

Exhibit Index

Exhibit No.		Description
99.1		Unaudited Consolidated Financial Statements and Notes of WORK Medical Technology Group LTD for the Six Months Ended March 31, 2025 and 2024
99.2		Management’s Discussion and Analysis of Financial Condition and Results of Operations
101. INS		Inline XBRL Instance Document
101.SCH		Inline XBRL Taxonomy Extension Schema Document
101.CAL		Inline XBRL Taxonomy Extension Calculation Linkbase Document
101.DEF		Inline XBRL Taxonomy Extension Definition Linkbase Document
101.LAB		Inline XBRL Taxonomy Extension Label Linkbase Document
101.PRE		Inline XBRL Taxonomy Extension Presentation Linkbase Document
104		Cover Page Interactive Data File (formatted as Inline XBRL and contained in Exhibit 101)

2

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

	WORK Medical Technology Group LTD
Date: August 25, 2025	By:	/s/ Shuang Wu
	Name:	Shuang Wu
	Title:	Chief Executive Officer

3